Asian Spectator

Men's Weekly

.

Constantly Strategical Planning High-Growth Sectors, Grand Pharma’s 2022 Interim Results Continue to Grow

HONG KONG SAR - Media OutReach - 11 August 2022- Grand Pharma (0512.HK, the "Company") announced its 2022 interim results recently. During the first half of 2022 (the "Period"), the Company recorded revenue of approximately HKD 5.21 billion, representing an increase of 14.1% YoY; net profit attributable to owners of the company of HKD 1.09 billion (excluding the changes in investment in Telix), representing an increase of 20.1% YoY.

Magazine

Cracking the code: How a “prediction machine” is resurrecting the Singapore Stone

Singapore Stonewikipedia.org, CC BYSeveral years ago, my linguistic research team and I began developing a computational tool we call ‘Read-y Grammarian’. Our goal was to reconstruct the h...

Transisi energi berkeadilan: benar nyata atau hanya jargon semata?

TomFisk?Pexels, CC BYDunia memang sedang bergerak menuju energi yang lebih hijau demi kelestarian Bumi. Namun di lain sisi, ada jutaan pekerja yang menggantungkan hidup dari industri ekstraktif, seper...

Gaya maskulin pemerintah memulihkan bencana Sumatra: Hanya mau mengatur, tapi enggan menafkahi dan melindungi

Presiden Prabowo Subianto saat meninjau posko pengungsi di MAN 1 Langkat, Kabupaten Langkat, Sumatra Utara, pada 13 Desember 2025.Kris/Biro Pers Sekretariat Presiden● Dalam penanganan bencana, n...